S&P 500   4,513.04
DOW   34,022.04
QQQ   387.12
S&P 500   4,513.04
DOW   34,022.04
QQQ   387.12
S&P 500   4,513.04
DOW   34,022.04
QQQ   387.12
S&P 500   4,513.04
DOW   34,022.04
QQQ   387.12

Alimera Sciences Insider Trades

-0.20 (-3.82%)
(As of 12/1/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
9,595 shs
Average Volume
61,048 shs
Market Capitalization
$34.90 million
P/E Ratio
Dividend Yield

Alimera Sciences (NASDAQ:ALIM) Insider Buying and Selling Activity

Insider Ownership

Number Of
Insiders Buying
(Last 12 Months)

Amount Of
Insider Buying
(Last 12 Months)
$195.82 K

Number Of
Insiders Selling
(Last 12 Months)

Amount Of
Insider Selling
(Last 12 Months)

Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter

Get ALIM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Alimera Sciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Alimera Sciences (NASDAQ ALIM) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/5/2021Richard S Eiswirth JrCEOBuy1,400$5.50$7,700.00  
11/3/2021James R LargentDirectorBuy10,000$4.31$43,100.00  
11/3/2021John Philip JonesCFOBuy5,000$4.08$20,400.00  
11/3/2021Richard S Eiswirth JrCEOBuy28,005$4.45$124,622.25  
4/8/2021Philip AshmanCOOSell45$9.62$432.9019,379  
12/10/2019John Philip JonesCFOBuy1,000$9.44$9,440.00
11/21/2019John SnisarenkoDirectorBuy10,000$4.95$49,500.0010,000  
11/19/2019James R LargentDirectorBuy3,000$5.11$15,330.003,000  
11/14/2019Richard S Eiswirth JrCEOBuy100,000$5.21$521,000.00
5/7/2018Richard S Eiswirth JrInsiderBuy10,000$1.05$10,500.00171,770  
2/6/2018Armistice Capital Master FundMajor ShareholderBuy20,000$1.14$22,800.00  
2/2/2018Armistice Capital, LlcMajor ShareholderBuy8,000$1.16$9,280.00  
1/19/2018C. Daniel MyersCEOSell52,900$1.20$63,480.00101,511  
1/19/2018Philip AshmanSVPSell25,500$1.20$30,600.0012,750  
1/19/2018Richard S Eiswirth JrInsiderSell13,410$1.20$16,092.0084,779  
1/17/2018C. Daniel MyersCEOSell52,900$1.23$65,067.00154,411  
1/17/2018Philip AshmanSVPSell25,500$1.23$31,365.0038,250  
1/17/2018Richard S Eiswirth JrInsiderSell14,494$1.23$17,827.6298,619  
3/10/2017C. Daniel MyersCEOSell21,172$1.39$29,429.08180,861  
9/15/2016Richard S Eiswirth JrInsiderSell51,471$1.51$77,721.2186,445  
4/21/2016L.P. BavpMajor ShareholderSell478,673$2.59$1,239,763.074,477,291  
12/16/2015Richard S. Eiswirth, Jr.CFOSell46,669$2.31$107,805.3934,974  
12/8/2015James E FlynnInsiderBuy272,249$3.01$819,469.49  
12/3/2015James E FlynnInsiderBuy243,252$3.00$729,756.00  
10/30/2015James E FlynnInsiderBuy16,542$3.00$49,626.00  
10/28/2015James E FlynnInsiderBuy59,342$3.00$178,026.00  
10/26/2015James E FlynnInsiderBuy60,364$3.00$181,092.00  
10/21/2015James E FlynnMajor ShareholderBuy160,684$3.00$482,052.00  
10/20/2015James E FlynnMajor ShareholderBuy100,130$3.00$300,390.00  
10/19/2015James E FlynnMajor ShareholderBuy129,226$2.92$377,339.92  
10/15/2015Richard S. Eiswirth, Jr.CFOSell13,625$2.69$36,651.2534,974  
10/9/2015James E FlynnInsiderBuy321,785$2.42$778,719.70  
9/3/2015Calvin W RobertsDirectorBuy6,424$3.00$19,272.006,389  
8/21/2015Kenneth GreenSVPSell20,000$3.29$65,800.0048,235  
8/17/2015Kenneth GreenSVPSell20,000$3.90$78,000.0068,235  
6/26/2015L.P. BavpMajor ShareholderSell1,024$5.00$5,120.00  
6/19/2015L.P. BavpMajor ShareholderSell5,568$5.00$27,840.00  
5/1/2015C. Daniel MyersCEOSell2,000$4.37$8,740.00  
4/27/2015L.P. BavpMajor ShareholderSell3,114$5.02$15,632.28  
4/23/2015L.P. BavpMajor ShareholderSell4,362$5.00$21,810.00  
4/20/2015L.P. BavpMajor ShareholderSell30,300$5.03$152,409.00  
4/15/2015L.P. BavpMajor ShareholderSell35,800$5.03$180,074.00  
4/14/2015L.P. BavpMajor ShareholderSell18,400$5.01$92,184.00  
4/13/2015L.P. BavpMajor ShareholderSell100$5.00$500.00  
3/6/2015Richard S Eiswirth JrCFOBuy10,000$4.84$48,400.00  
3/2/2015C. Daniel MyersCEOSell2,000$5.21$10,420.00  
1/2/2015C. Daniel MyersCEOSell2,000$5.51$11,020.00  
1/2/2015David HollandSVPSell5,000$5.56$27,800.00  
12/1/2014C. Daniel MyersCEOSell2,000$5.99$11,980.00  
12/1/2014David HollandSVPSell5,000$5.71$28,550.00  
10/27/2014L.P. BavpMajor ShareholderSell57,918$6.34$367,200.12  
10/1/2014C. Daniel MyersCEOSell2,000$5.42$10,840.00  
10/1/2014David HollandSVPSell5,000$5.26$26,300.00  
10/1/2014Patrick LeeMajor ShareholderSell621,191$5.42$3,366,855.22  
9/30/2014Patrick LeeMajor ShareholderSell354,062$5.42$1,919,016.04  
9/29/2014Patrick LeeMajor ShareholderSell240,662$5.47$1,316,421.14  
9/11/2014L.P. BavpMajor ShareholderSell2,816$6.25$17,600.00  
9/4/2014L.P. BavpMajor ShareholderSell39,500$6.33$250,035.00  
8/29/2014L.P. BavpMajor ShareholderSell7,400$6.27$46,398.00  
8/28/2014L.P. BavpMajor ShareholderSell3,000$6.27$18,810.00  
8/1/2014David HollandSVPSell5,000$5.64$28,200.00  
7/1/2014David HollandSVPSell5,000$6.02$30,100.00  
5/1/2014David HollandSVPSell5,000$5.93$29,650.00  
3/4/2014C. Daniel MyersCEOSell22,775$7.10$161,702.50  
3/4/2014David HollandSVPSell10,000$6.84$68,400.00  
3/4/2014Susan CaballaInsiderSell8,931$7.01$62,606.31  
1/16/2014Domain Partners Vi, L.P.Major ShareholderSell296,760$6.39$1,896,296.40  
7/17/2013Polaris Venture Management CoInsiderSell122,937$4.80$590,097.60  
6/20/2013Domain Partners Vi, L.P.Major ShareholderSell10,516$5.01$52,685.16  
6/19/2013Domain Partners Vi, L.P.Major ShareholderSell55,278$5.39$297,948.42  
6/18/2013Polaris Venture Management CoInsiderSell37,063$5.44$201,622.72  
6/17/2013Domain Partners Vi, L.P.Major ShareholderSell126,709$5.29$670,290.61  
6/11/2013Domain Partners Vi, L.P.Major ShareholderSell5,337$5.00$26,685.00  
5/17/2013David HollandSVPSell30,000$4.13$123,900.00  
5/16/2013Domain Partners Vi, L.P.Major ShareholderSell44,242$4.60$203,513.20  
12/13/2012Peter J Pizzo IIIDirectorBuy5,000$1.44$7,200.00  
12/3/2012C. Daniel MyersCEOSell7,700$1.95$15,015.00  
(Data available from 1/1/2013 forward)

Alimera Sciences (NASDAQ:ALIM) Insider Trade Frequently Asked Questions

Who is on Alimera Sciences's Insider Roster?

The list of insiders at Alimera Sciences includes James R Largent, John Philip Jones, John Snisarenko, Philip Ashman, and Richard S Eiswirth Jr.Learn more on ALIM's insiders

What percentage of Alimera Sciences stock is owned by insiders?

13.50% of Alimera Sciences stock is owned by insiders. Learn more on ALIM's insider holdings

Which Alimera Sciences insiders have been buying company stock?

The following insiders have purchased Alimera Sciences stock in the last 24 months: James R Largent ($43,100.00), John Philip Jones ($29,840.00), and Richard S Eiswirth Jr ($132,322.25).

How much insider buying is happening at Alimera Sciences?

Insiders have purchased a total of 45,405 Alimera Sciences shares in the last 24 months for a total of $205,262.25 bought.

Which Alimera Sciences insiders have been selling company stock?

The following insider sold Alimera Sciences stock in the last 24 months: Philip Ashman ($432.90).

How much insider selling is happening at Alimera Sciences?

Insiders have sold a total of 45 Alimera Sciences shares in the last 24 months for a total of $432.90 sold.

This page was last updated on 12/2/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.